Legal Representation
Attorney
Daniel M. Gurfinkel
USPTO Deadlines
Next Deadline
14 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
November 19, 2025
Extension Available
Until November 19, 2025
Application History
25 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 19, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 19, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 19, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 19, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 19, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 24, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 24, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 4, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 16, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 14, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 14, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 14, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 29, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 29, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 29, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 1, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 1, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 1, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 6, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 6, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 6, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 27, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 11, 2023 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jul 10, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 9, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemicals for use in the manufacture of pharmaceuticals, namely, saccharides and polysaccharides, nucleotides and poly nucleotides, amino acids, peptides and polypeptides, antimicrobial preservatives, esters, fatty acids, flavor improvers, preservatives, reagents for testing sterility, pharmaceutical intermediates and tragacanth gum; Biological preparations for use in industry, particularly in the manufacture of pharmaceuticals, namely, saccharides and polysaccharides, nucleotides and poly nucleotides, amino acids, peptides and polypeptides, antimicrobial preservatives, esters, fatty acids, flavor improvers, preservatives, reagents for testing sterility, pharmaceutical intermediates and tragacanth gum
Class 005
Biochemical pharmaceutical preparations for human use, namely, anticoagulant preparations
Class 040
Manufacturing services for others in the field of pharmaceuticals, namely, the manufacturing of biological assays and kits, and biological reagents for use in the fields of science, medicine and laboratory research
Additional Information
Design Mark
The mark consists of the stylized wording BIOCHEMSIOUXCITY appearing to the right of a shaded hexagon, with a small letter "o" on its top right-hand corner and a stylized capital letter B appearing within the hexagon.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
001
005
040
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOCHEM SIOUX CITY"